Corrigendum to “results from Three Phase 1 Trials of NNC9204-1177, a Glucagon/glp-1 Receptor Co-Agonist: Effects on Weight Loss and Safety in Adults with Overweight or Obesity” [mol Metab 78 (2023) 101801]
Molecular metabolism（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined